Nonetheless, there are limitations to our study, and additional investigation is required to comprehensively clarify the fundamental mechanisms accountable for the beneficial impacts of SIRT1 and IL-11 in the context of CF. The gene discussed is SIRT1; the disease is cystic fibrosis.